Ketovite Liquid
- Name:
Ketovite Liquid
- Company:
Essential Pharmaceuticals Ltd
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 12/10/20

Summary of Product Characteristics last updated on medicines.ie: 12/10/2020
Click on this link to Download PDF directly
Essential Pharmaceuticals Ltd

Company Products
Medicine Name | Active Ingredients |
---|---|
Medicine Name Ketovite Liquid | Active Ingredients Multivitamins |
Medicine Name Ketovite tablets | Active Ingredients Multivitamins |
Items Per Page :
1 - 0 of 2 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 12 October 2020 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 12 October 2020 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Updated on 12 June 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation number
Updated on 12 June 2019 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Update to MAH and PA number
Updated on 3 July 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 3 July 2017 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
Updated on 22 January 2016 PIL
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 19 June 2015 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 4.8 (undesirable effects) statement about how to report side effects has been added:$0$0Reporting ofsuspected adverse reactions: $0$0Reporting suspected adverse reactions afterauthorisation of the medicinal product is important. It allows continuedmonitoring of the benefit/risk balance of the medicinal product. Healthcareprofessionals are asked to report any suspected adverse reactions via $0$0HPRA Pharmacovigilance $0$0Earlsfort Terrace $0$0IRL - Dublin 2 $0$0Tel: +353 1 6764971 $0$0Fax: +353 1 6762517 $0$0Website: www.hpra.ie $0$0e-mail: medsafety@hpra.ie $0$0
Updated on 19 June 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 10 June 2015 PIL
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 5 October 2012 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
None provided
Updated on 3 October 2012 PIL
Reasons for updating
- New PIL for medicines.ie